Multiple Myeloma: Italy Approves Early-Line CAR-T Therapy
Beyond the Last Resort: How Early-Intervention CAR-T Therapy is Redefining Multiple Myeloma Survival For years, CAR-T cell therapy was viewed as the “Hail Mary” of oncology—a high-stakes, last-effort intervention reserved for patients who had failed every other available treatment. However, a seismic shift is occurring in the clinical landscape, moving this revolutionary immunotherapy from the … Read more
